Vitamin D and Glaucoma Risk: Current Evidence and Therapeutic Implications
Quality in Sport · 05.06.2026 · 57 · 72603
DOI: 10.12775/qs.2026.57.72603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Quality in Sport, online erschienen am 05.06.2026. Verfasst von Marta Zarzycka und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction and purpose Glaucoma is a chronic, progressive optic neuropathy and a leading cause of irreversible blindness worldwide. Increasing evidence suggests that, beyond intraocular pressure, systemic and metabolic factors may contribute to its pathogenesis. Vitamin D, known for its immunomodulatory and neuroprotective properties, has emerged as a potential factor influencing glaucoma risk. The aim of this study was to evaluate the relationship between vitamin D supplementation and the risk of developing glaucoma. Material and method A narrative review of current literature, including experimental, observational, and clinical studies, was conducted to assess the association between vitamin D status, supplementation, and glaucoma-related outcomes such as intraocular pressure and optic nerve damage. Particular attention was given to studies analyzing serum 25(OH)D levels, supplementation patterns, and disease progression.
Results
Experimental studies indicate that calcitriol may reduce intraocular pressure and improve aqueous humor outflow, while observational studies often demonstrate an inverse relationship between serum vitamin D levels and glaucoma risk. However, clinical trials assessing supplementation have yielded inconclusive results, with some showing no significant effect on intraocular pressure. Variability in study design, population characteristics, and lack of detailed supplementation data limit the interpretation of findings. Additionally, vitamin D may exert neuroprotective effects independent of pressure regulation.
Conclusions
Vitamin D may play a supportive role in glaucoma prevention through systemic and ocular mechanisms however, current evidence is insufficient to confirm a clear protective effect of supplementation. Further large-scale, well-designed prospective studies are required to clarify its clinical significance.
Zitieren
APA
Zarzycka, M., Lorek, J., Perski, K., Grzywna, W. P., Chrabąszcz, J. M., Baltyzar, K. A., Kurek, M. M., Polit-Różycka, O. K., & Gadzalski, K. (2026). Vitamin D and Glaucoma Risk: Current Evidence and Therapeutic Implications. Quality in Sport, 57, 72603. https://doi.org/10.12775/qs.2026.57.72603
Vancouver
Zarzycka M, Lorek J, Perski K, Grzywna WP, Chrabąszcz JM, Baltyzar KA, et al. Vitamin D and Glaucoma Risk: Current Evidence and Therapeutic Implications. Quality in Sport. 2026;57:72603. doi:10.12775/qs.2026.57.72603
BibTeX
@article{Zarzycka2026,
author = {Zarzycka, Marta and Lorek, Julia and Perski, Karol and Grzywna, Wojciech Piotr and Chrabąszcz, Joanna Małgorzata and Baltyzar, Konstancja Anna and Kurek, Maria Michalina and Polit-Różycka, Oliwia Kinga and Gadzalski, Krzysztof},
title = {Vitamin D and Glaucoma Risk: Current Evidence and Therapeutic Implications},
journal = {Quality in Sport},
year = {2026},
volume = {57},
pages = {72603},
doi = {10.12775/qs.2026.57.72603}
}
EUVIMED